- The move followed different circumstances, including licensing issues
- Certificate may be withdrawn when the holder requests discontinuation
- Ensuring only safe, effective, and high-quality medicines remain in circulation
The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the immediate withdrawal, suspension, or cancellation of 101 pharmaceutical products across Nigeria.
Eko Hot Blog reports that in a statement posted on its official X handle on Tuesday, the agency declared that the affected medicines “are no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale, or use within Nigeria.”
EDITOR’S PICK
- Hon. Anomo Reassures Students as FEDSA Pays Congratulatory Visit
- Dangote, PENGASSAN Dispute Moves to NSA’s Office in Closed-Door Talks
- Tinubu Arrives Owerri, Begins Official Visit to Imo
The decision affects a wide range of commonly used drugs, including Abacavir, Amlodipine, various artemether/lumefantrine antimalarial formulations, valsartan cardiovascular products, Norditropin (growth hormone injections), diabetes treatments such as Januvia and Janumet, as well as several inhalers and eye drops.
NAFDAC explained that the move followed different circumstances, including licensing issues and voluntary withdrawals by the market authorisation holders.
It clarified that a product’s registration certificate may be withdrawn when the holder requests discontinuation, suspended if licensing conditions are no longer met, or cancelled if the agency revokes the certificate outright.
The decision comes against the backdrop of growing global concerns over the prevalence of substandard and falsified medicines. According to the World Health Organisation, about 10 per cent of medicines in low- and middle-income countries fall into these categories, raising public health risks.
Consumers, healthcare professionals, and distributors are advised to review the full list of affected medicines, which can be accessed via this link: https://bit.ly/4pylYtQ
NAFDAC further assured the public of its commitment to safeguarding health by ensuring only safe, effective, and high-quality medicines remain in circulation.
FURTHER READING
- Olubadan Ladoja Quits Politics, Gives Reason
- ‘Many Will Betray You’ – Jonathan Warned Against 2027 Presidential Ambition
- Court Fixes Fresh Date for Sowore’s Arraignment on Cybercrime Charges
Click here to watch video of the week
